Human Cytomegalovirus Infection Primes Fetal Natural Killer Cells for Fc-Mediated Antiviral Defense
J Infect Dis
.
2023 Mar 28;227(6):739-741.
doi: 10.1093/infdis/jiac308.
Authors
Eleanor C Semmes
1
,
Sallie R Permar
2
Affiliations
1
Medical Scientist Training Program, Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.
2
Department of Pediatrics, Weill Cornell Medicine, New York City, New York, USA.
PMID:
35876548
DOI:
10.1093/infdis/jiac308
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antiviral Agents
Cytomegalovirus Infections*
Herpesviridae Infections*
Humans
Killer Cells, Natural
Substances
Antiviral Agents
Grants and funding
T32 GM007171/GM/NIGMS NIH HHS/United States
T32 GM145449/GM/NIGMS NIH HHS/United States
P01 AI129859/AI/NIAID NIH HHS/United States